ARCHIVES

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

This article is from The Cancer Letter archive.

Vol. 15 No. 42 | November 3, 1989

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

NCI Contract Awards

November 1, 1996

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995